These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34678226)

  • 1. LncRNAs in tumor microenvironment: The potential target for cancer treatment with natural compounds and chemical drugs.
    Liu QP; Lin JY; An P; Chen YY; Luan X; Zhang H
    Biochem Pharmacol; 2021 Nov; 193():114802. PubMed ID: 34678226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products: Potential targets of TME related long non-coding RNAs in lung cancer.
    Malla RR; Padmaraju V; Marni R; Kamal MA
    Phytomedicine; 2021 Dec; 93():153782. PubMed ID: 34627097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of long non-coding RNAs in breast cancer microenvironment.
    Yao W; Wang L; Liu F; Xia L
    Pathol Res Pract; 2023 Aug; 248():154707. PubMed ID: 37506626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Roles of Long non-coding RNAs in The Tumor Microenvironment.
    Zhou L; Zhu Y; Sun D; Zhang Q
    Int J Biol Sci; 2020; 16(12):2094-2103. PubMed ID: 32549757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The landscape of long non-coding RNAs in tumor stroma.
    Uddin MN; Wang X
    Life Sci; 2021 Jan; 264():118725. PubMed ID: 33166593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategic and Innovative Roles of lncRNAs Regulated by Naturally-derived Small Molecules in Cancer Therapy.
    Alkan AH; Ensoy M; Cansaran-Duman D
    Curr Med Chem; 2024; 31(40):6672-6691. PubMed ID: 37921177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Compounds as Metabolic Modulators of the Tumor Microenvironment.
    Dias AS; Helguero L; Almeida CR; Duarte IF
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34201298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
    Lin YH; Wu MH; Yeh CT; Lin KH
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.
    Jiang W; Xia J; Xie S; Zou R; Pan S; Wang ZW; Assaraf YG; Zhu X
    Drug Resist Updat; 2020 May; 50():100683. PubMed ID: 32146422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNAs in cancer: From discovery to therapeutic targets.
    Choudhari R; Sedano MJ; Harrison AL; Subramani R; Lin KY; Ramos EI; Lakshmanaswamy R; Gadad SS
    Adv Clin Chem; 2020; 95():105-147. PubMed ID: 32122521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-mediated lncRNA-induced immune cell plasticity in cancer immunopathogenesis.
    Lu J; Ma H; Wang Q; Song Z; Wang J
    Int Immunopharmacol; 2024 Nov; 141():112967. PubMed ID: 39181018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm.
    Zhang J; Wu L; Wang C; Xie X; Han Y
    Drug Des Devel Ther; 2024; 18():1385-1398. PubMed ID: 38689609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNAs in cancer immunity: a new avenue in drug discovery.
    Dutta A; Roy A; Chatterjee S
    Drug Discov Today; 2021 Jan; 26(1):264-272. PubMed ID: 32827755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.
    Sun Z; Yang S; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Xu J; Xia K; Chang Y; Liu J; Yuan W
    Mol Cancer; 2018 Apr; 17(1):82. PubMed ID: 29678180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs as sensors of tumor microenvironmental stress.
    Lv Y; Lv Y; Wang Z; Yuan K; Zeng Y
    J Exp Clin Cancer Res; 2022 Jul; 41(1):224. PubMed ID: 35842651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
    Abu N; Hon KW; Jeyaraman S; Jamal R
    Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment.
    Yang P; Ding J; Bian Y; Ma Z; Wang K; Li J
    Med Oncol; 2022 May; 39(7):108. PubMed ID: 35578054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and lncRNAs in gastrointestinal cancers.
    Huang L; Wang W; Hu Z; Guan C; Li W; Jiang X
    Pathol Res Pract; 2019 Dec; 215(12):152687. PubMed ID: 31640897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting long non coding RNA by natural products: Implications for cancer therapy.
    Homayoonfal M; Asemi Z; Yousefi B
    Crit Rev Food Sci Nutr; 2023; 63(20):4389-4417. PubMed ID: 34783279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs in the doxorubicin resistance of cancer cells.
    Ashrafizaveh S; Ashrafizadeh M; Zarrabi A; Husmandi K; Zabolian A; Shahinozzaman M; Aref AR; Hamblin MR; Nabavi N; Crea F; Wang Y; Ahn KS
    Cancer Lett; 2021 Jun; 508():104-114. PubMed ID: 33766750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.